natgillin/translations-raw huggingface dataset:
Ropinirole is a dopamine agonist, which means that it imitates the action of dopamine. 
Ropinirol je agonist dopamina, kar pomeni, da posnema delovanje dopamina.
People who are hypersensitive (allergic) to ropinirole should avoid contact with Clevor. 
Ljudje, ki so preobčutljivi za (alergični na) ropinirol, se morajo izogibati stiku z zdravilom Clevor.
Pregnant or breast-feeding women should not handle this medicine. 
Nosečnice in doječe matere ne smejo rokovati s tem zdravilom.
Clevor must not be used in dogs: 
Zdravilo Clevor se ne sme uporabljati pri psih:
What are the risks associated with Clevor? 
Kakšna tveganja so povezana z zdravilom Clevor?
Why is Clevor authorised in the EU? 
Zakaj je zdravilo Clevor odobreno v EU?
An overview of Clevor and why it is authorised in the EU 
Pregled zdravila Clevor in zakaj je odobreno v EU
It contains the active substance ropinirole. 
Vsebuje zdravilno učinkovino ropinirol.
A second dose was given after 20 minutes to 13% of the dogs as they had not vomited. 
Po 20 minutah so dali drugi odmerek 13 % psov, ki še niso bruhali.
The medicine should only be given by a veterinarian or under his/her close supervision and can only be obtained with a prescription. 
Zdravilo lahko daje samo veterinar oziroma se lahko daje pod njegovim skrbnim nadzorom, predpisovanje in izdaja zdravila pa je le na recept.
In the group of 32 dogs which received placebo eye drops only one dog vomited. 
V skupini 32 psov, ki so prejeli kapljice za oko s placebom, je bruhal samo en pes.
The most common side effects with Clevor (which may affect more than 1 in 10 animals) are shortlived, mild hyperaemia (redness) of the eye, discharge from the eye, protrusion of the third eyelid, blepharospasm (closure of the eyelids due to muscle contraction), short-lived mild lack of energy and increased heart rate. 
Najpogostejši neželeni učinki zdravila Clevor (ki lahko prizadenejo več kot 1 žival od 10) so kratkotrajna, blaga hiperemija (pordelost) oči, izcedek iz oči, dvig tretje veke, blefarospazem (zapiranje vek zaradi mišičnih krčev), kratkotrajno blago pomanjkanje energije in pospešen srčni utrip.
What benefits of Clevor have been shown in studies? 
Kakšne koristi je zdravilo Clevor izkazalo v študijah?
What is Clevor and what is it used for? 
Kaj je zdravilo Clevor in za kaj se uporablja?
For more information about using Clevor, see the package leaflet or contact your veterinarian or pharmacist. 
Za več informacij glede uporabe zdravila Clevor glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
Clevor is a veterinary medicine used to induce vomiting in dogs. 
Clevor je zdravilo za uporabo v veterinarski medicini za sprožanje bruhanja pri psih.
• with central nervous system depression (low levels of consciousness), seizures (fits) or other problems with the nervous system which could lead to inhalation pneumonia (lung damage due to content from the stomach entering the lungs). 
• z depresijo osrednjega živčevja (znižano ravnjo zavesti), epileptičnimi napadi (krči) ali drugimi težavami z živčevjem, ki bi lahko povzročile aspiracijsko pljučnico (poškodbo pljuč, ki je posledica vstopa želodčne vsebine v pljuča);
Clevor is an eye drop solution, given into the eye at a dose of 1-8 drops according to the dog's bodyweight. 
Zdravilo Clevor je raztopina za kapljice za oko, ki se daje v oči v odmerku od ene do osmih kapljic, odvisno od telesne mase psa.
• which are hypoxic (have lower than normal oxygen levels in the blood), dyspnoeic (have difficulty breathing) or lack pharyngeal (swallowing) reflexes. 
• ki so hipoksični (imajo znižano raven kisika v krvi), dispneični (imajo težave z dihanjem) ali nimajo faringealnih refleksov (refleksov požiranja);
For the full list of side effects and restrictions of Clevor, see the package leaflet. 
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Clevor glejte navodilo za uporabo.
By stimulating this part of the brain ropinirole triggers vomiting. 
Ropinirol s stimuliranjem tega dela možganov sproži bruhanje.
If a dose of more than one drop is needed it should be divided between both eyes and when 6 or more drops are to be given the dose should be divided into 2 separate treatments given 12 minutes apart. 
Kadar je treba dati šest kapljic ali več, je treba odmerek razdeliti v dve ločeni aplikaciji, ki jih damo eno do dve minuti narazen.
• which have swallowed sharp foreign objects, corrosive agents, volatile substances or organic solvents. 
• ki so pogoltnili ostre tujke, korozivna sredstva, hlapne snovi ali organska topila.
Dopamine is a messenger substance in the part of the brain which controls vomiting. 
Dopamin je prenašalec v tistem delu možganov, ki nadzira bruhanje.
If symptoms occur, medical advice should be sought and the package leaflet or label shown to the doctor. 
Če se pojavijo neželeni učinki, nemudoma poiščite zdravniško pomoč in zdravniku pokažite navodilo za uporabo ali nalepko.
How is Clevor used? 
Kako se zdravilo Clevor uporablja?
How does Clevor work? 
Kako zdravilo Clevor deluje?
List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states 
SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE ZDRAVILA, PREDLAGATELJEV, IMETNIKOV DOVOLJENJA ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
Line Range Limited, c/o Orbis consumer products Limited, 
Velika Britanija Line Range Limited, c/o Orbis consumer products Limited,
Bell Sons & Company Druggist limited. 
Velika Britanija Bell Sons & Company Druggist limited.
Clarix sans sucre 
Clarix sans sucre Sirup
Caltoson Balsamico Tablets 
Caltoson Balsamico Tableta
Oral suspension Oral use 
Peroralna suspenzija Peroralna uporaba
Diagonal, 67-69 Barcelona 08019 Spain pholcodine ; cineol ; cherry laurel water ; menthol ; terpineol ; benzocaine 
Diagonal, 67-69 Barcelona 08019 Spain folkodin ; cineol ; voda lovorikovca mentol ; terpineol ; benzokain
Pinewood Laboratories Limited, 
Velika Britanija Pinewood Laboratories Limited,
Luxembourg COOPERATION PHARM.FRANCAISE PLACE LUCIEN AUVERT 77020 MELUN CEDEX France 
Luksemburg COOPERATION PHARM.FRANCAISE PLACE LUCIEN AUVERT 77020 MELUN CEDEX France
Beecham Group PLC, 980 Great West Road, Brentford, 
Velika Britanija Beecham Group PLC, 980 Great West Road, Brentford,
Belgium pholcodine thiophene carboxylate eucalyptus huile essentielle parahydroxybenzoate de methyle parahydroxybenzoate de propyle 
Belgium folkodin tiofenijev karboksilat esencialno olje evkaliptola metilparahidroksib enzoat parahydroxybenzo ate de propyle
Day Nurse Capsules Capsule, hard Oral use 
Day Nurse Capsules Kapsula, trda
Wise Pharmaceuticals Limited, 
Velika Britanija Wise Pharmaceuticals Limited,
Sterling Pharmaceuticals Limited, 
Velika Britanija Sterling Pharmaceuticals Limited,
Alliance Pharmaceuticals Limited, 
Velika Britanija Alliance Pharmaceuticals Limited,
Belgium Sanofi-Aventis Belgium NV Culliganlaan 1C 
Sanofi-Aventis Belgium NV
Ayrton Saunders Limited, North Way, 
Velika Britanija Ayrton Saunders Limited,
myrte (huile essentielle de) (deterpenee) ; alpha-terpinéol ; pholcodine 
mirta (esencialno olje), alfaterpineol ; folkodin
Promethazine Hydrochloride, Paracetamol, Dextromethorphan hydrobromide Pholcodine; 
Promethazine Hydrochloride, Paracetamol, Dekstrometorfanij ev hidrobromid Folkodin;
Thornton & Ross Limited, Linthwaite, 
Velika Britanija Thornton & Ross Limited,
Cotrane Pholcodine Syrup 
Cotrane Pholcodine Sirup
Pholco-mereprine 
Pholco-mereprine Sirup
Belgium doxylamine pholcodine benzoate sodique sulfogaiacol 
Belgium doksilamin folkodin benzojska kislina sulfogaiakol
Pholcodyl, sirop 
Pholcodyl, sirop Sirup
Ephedromel, sirop Syrup 
Ephedromel, sirop Sirup
biclotymol ; cinéole ; pholcodine 
biklotimol ; cineol; folkodin
Belgium pholcodine 15 mg/15ml Sulfogaiacol 300 mg/15ml 
8560 Wevelgem Belgium folkodin 15 mg/15ml Sulfogaiakol 300 mg/15ml
Cotrane Folcodine 
Cotrane Folcodine Sirup
Day time cold relief 
Day time cold relief Peroralna tekočina Peroralna uporaba
Psedoephedrine Hydrochloride ; 
Psevdoefedrin Hydrochloride ;
Biocalyptol, sirop 
Biocalyptol, sirop Sirup
Pholcodine, Chlorphenamine, Biclotymolm 
Folkodin, Klorfenamin, Biklotimolm
Belgium pholcodine eucalyptolum camphora syntheticum gaiacolum phenolum 
8560 Wevelgem Belgium folkodin evkaliptolum camphora syntheticum gaiacolum fenol
Pholco Mereprine 
Pholco Mereprine Sirup
Pseudoephedrine 
Psevdoefedrin
Belgium camphre eucalyptol gaiacol phenol pholcodine 
Belgium kafra evkaliptol gaiacol fenol folkodin
pholcodine ; érysimum (extrait sec d') 
folkodin ; šebenik (suhi ekstrakt)
Pholcodine, Chlorphenamine, Biclotymol 
Folkodin, Klorfenamin, Biklotimol
Pseudoephedrine Hydrochloride ; Pholcodine ; 
Psevdoefedrin Hydrochloride ; Folkodin ;
Ernest Jackson and company Limited, 29 High Street, Crediton, 
Velika Britanija Ernest Jackson and company Limited,
Wimblehurst Road, Horsham, 
Velika Britanija Novartis Consumer Health UK Limited, Wimblehurst Road, Horsham,
MYRTE (huile essentielle de) (deterpenee) ; pholcodine 
Mirta (esencialno olje), ; folkodin
biclotymol ; chlorphénamine (maléate de) ; pholcodine 
biklotimol ; klorfenaminijev maleat ; folkodin
Tixylix Dry cough 
Tixylix Dry cough Peroralna raztopina Peroralna uporaba
Night time Cold relief 
Night time Cold relief Peroralna raztopina Peroralna uporaba
Chlorpheniramine maleate 
Klorfenaminijev maleat
Pholcodine, Ephedrine Hydrochloride, Chlorphenamine Maleate 
Efedrinhidroklorid, Klorfenamin Maleate
Pseudoephedrine hydrochloride 
Psevdoefedrin hydrochloride
Kalii guaiacolsulfonas 47,5 mg/5ml Natrii benzoas 50 mg/5ml 
Natrii benzoas 50 mg/5ml
Capsule, hard Oral use 
Kapsula, trda
Paracetamol, Pseudoephedrine hydrochloride, Pholcodine 
Paracetamol, Psevdoefedrin hydrochloride, Folkodin
Trophires Adultes 
Trophires Adultes Sirup
19,750mg/100 ml; 
19,750mg/100ml; 131 mg/100ml
Pholcodine Linctus BP Oral solution 
Pholcodine Linctus BP Peroralna raztopina Peroralna uporaba
9830 Sint-Martens-Latem Belgium pholcodine 5 mg/5ml Doxylaminii succinas 5 mg/5ml 
Belgium folkodin 5 mg/5ml Doksilaminijev sukcinat 5 mg/5ml Kalii guaiakol sulfonas 47,5 mg/5ml
Diphenhydramine Psedoephedrine Hydrochloride 
Diphenhydramine Psevdoefedrin
Paracetamol Pseudoephedrine Hydrochloride Pholcodine 
Paracetamol Psevdoefedrinijev hidroklorid Folkodin
HEPATOUM 
Pastila
pholcodine ; sodium (benzoate de) 
folkodin ; Natrii benzoas
GlaxoSmithKline Consumer Healthcare (Ireland) Limited, 
Velika Britanija LPC Medical (UK) Limited,
guaïfénésine ; pholcodine 
cineol; folkodin
Pseudoephedrine Hydrochloride ; Pholcodine 
Psevdoefedrin hydrochloride, Folkodin
chlorphénamine (maléate de) ; pholcodine 
Klorfenaminijev maleat ; Folkodin
Hard capsules 
Kapsula, trdas
pholcodine ; sulfogaïacol 
Folkodin ; Efedrinhidroklorid
• Risk Management Plan (RMP) 
• Načrt za obvladovanje tveganja (RMP - “Risk Management Plan”)
Not known (frequency cannot be estimated from the available data): - An allergic reaction. 
Neznana (pogostosti iz razpoložljivih podatkov ni mogoče oceniti): - Alergijska reakcija.
Your doctor will tell you if you need to change the amount of other medicines you take. 
Zdravnik vam bo povedal, če bo treba spremeniti količino drugih zdravil, ki jih jemljete.
Do not stop taking Vipidia without consulting your doctor first. 
Ne prenehajte jemati zdravila Vipidia, ne da bi se pred tem posvetovali z zdravnikom.
ATC code: A10BH04. 
Oznaka ATC: A10BH04
The absolute bioavailability of alogliptin is approximately 100%. 
Absolutna biološka uporabnost alogliptina je približno 100 %.
Frequencies are defined as very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from available data). 
Pogostnost neželenih učinkov je opredeljena kot zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Adults (≥ 18 years old) 
Odrasli (stari 18 let in starejši)
Your doctor will help you to decide whether to continue breast-feeding or to continue using Vipidia. 
Vaš zdravnik vam bo pomagal pri odločitvi, ali boste nadaljevali z dojenjem ali pa boste še naprej uporabljali zdravilo Vipidia.
It is important that you continue to take your other anti-diabetic medicine, and continue to follow the advice on diet and exercise that your nurse or doctor has given you. 
Pomembno je, da nadaljujete z jemanjem drugih zdravil za zdravljenje sladkorne bolezni in se držite navodil glede diete in telesne vadbe, ki sta vam jih dala medicinska sestra ali zdravnik.
What Vipidia is and what it is used for 
Kaj je zdravilo Vipidia in za kaj ga uporabljamo
Combination with other anti-diabetic medicinal products 
Kombinacije z drugimi antidiabetiki
Vipidia should be taken once daily with or without food. 
Zdravilo Vipidia je treba jemati enkrat na dan s hrano ali brez nje.
STOP taking Vipidia and contact a doctor immediately if you notice any of the following serious side effects: 
PRENEHAJTE jemati zdravilo Vipidia in nemudoma poiščite zdravniško pomoč, če opazite katerega koli od naslednjih resnih neželenih učinkov:
This may be 12.5 mg or 6.25 mg once a day, depending on the severity of your kidney disease. 
Ta je lahko 12,5 mg ali 6,25 mg enkrat na dan, odvisno od stopnje bolezni ledvic.
Vipidia should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. 
Zdravila Vipidia se ne sme uporabljati pri bolnikih s sladkorno boleznijo tipa 1 ali za zdravljenje diabetične ketoacidoze.
If you have kidney disease your doctor may prescribe you a reduced dose. 
Če imate bolezen ledvic, vam zdravnik lahko predpiše manjši odmerek.
The recommended dose of Vipidia is 25 mg once a day. 
Priporočeni odmerek zdravila Vipidia je 25 mg enkrat na dan.
Experience of alogliptin use in clinical studies in patients with congestive heart failure of New York Heart Association (NYHA) functional class III and IV is limited and caution is warranted in these patients. 
Izkušnje z uporabo alogliptina iz kliničnih študij pri bolnikih s kongestivnim srčnim popuščanjem funkcijskih razredov III in IV po New York Heart Association (NYHA) so omejene, zato je pri teh bolnikih potrebna previdnost.
The European Medicines Agency has deferred the obligation to submit the results of studies with Vipidia in one or more subsets of the paediatric population in the treatment of type 2 diabetes mellitus (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom Vipidia za eno ali več podskupin pediatrične populacije pri zdravljenju sladkorne bolezni tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
The adverse reactions are listed by system organ class and frequency. 
Neželeni učinki so navedeni po organskih sistemih in pogostnosti.
What you need to know before you take Vipidia 
Kaj morate vedeti, preden boste vzeli zdravilo Vipidia
MARKETING AUTHORISATION NUMBER(S) EU/1/13/844/001-030 
EU/1/13/844/001-030
It is used to lower blood sugar levels in adults with type 2 diabetes. 
Zdravilo uporabljamo za zniževanje vrednosti krvnega sladkorja pri odraslih s sladkorno boleznijo tipa 2.
Your doctor will prescribe Vipidia together with one or more other medicines to control your blood sugar levels. 
Zdravnik vam bo predpisal uporabo zdravila Vipidia skupaj z enim ali več drugimi zdravili za uravnavanje vrednosti krvnega sladkorja.
A decision on whether to discontinue breast-feeding or to discontinue alogliptin therapy should be made taking into account the benefit of breast-feeding for the child and the benefit of alogliptin therapy for the woman. 
Odločiti se je treba med prenehanjem dojenja in prenehanjem zdravljenja z alogliptinom, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti zdravljenja z alogliptinom za mater.
Other medicines and Vipidia 
Druga zdravila in zdravilo Vipidia
If you take more tablets than you should, or if someone else or a child takes your medicine, contact or go to your nearest emergency centre straight away. 
Če ste vzeli večji odmerek zdravila Vipidia, kot bi smeli Če ste vzeli več tablet, kot bi smeli, ali pa je vaše zdravilo vzela druga oseba ali otrok, se nemudoma obrnite na najbližji center za nujno medicinsko pomoč ali se odpravite tja.
The safety of alogliptin between the elderly (≥ 65 years old) and non-elderly (< 65 years old) was similar. 
Varnost alogliptina pri starostnikih (starih 65 let ali starejših) in mlajših bolnikih (mlajših od 65 let) je bila podobna.
Vipidia has no or negligible influence on the ability to drive and use machines. 
Zdravilo Vipidia nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
What Vipidia is and what it is used for What you need to know before you take Vipidia How to take Vipidia 
Kaj je zdravilo Vipidia in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Vipidia Kako jemati zdravilo Vipidia Možni neželeni učinki
The effect of alogliptin on fertility in humans has not been studied. 
Učinek alogliptina na plodnost pri ljudeh ni bil raziskan.
Patients should be observed closely for possible liver abnormalities. 
Bolnike je treba skrbno nadzirati glede možne okvare jeter.
Vipidia is available in blister packs containing 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 tablets. 
Zdravilo Vipidia je na voljo v pretisnih omotih, ki vsebujejo 10, 14, 28, 30, 56, 60, 84, 90, 98 ali 100 tablet.
Immune system disorders hypersensitivity not known 
Bolezni imunskega sistema preobčutljivost neznana
Pack sizes of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets. 
Velikosti pakiranj: 10, 14, 28, 30, 56, 60, 84, 90, 98 ali 100 filmsko obloženih tablet.
The most common adverse reaction in patients treated with 25 mg alogliptin was headache. 
Najpogostejši neželeni učinek pri bolnikih, ki so se zdravili z alogliptinom v odmerku 25 mg, je bil glavobol.
Vipidia works to increase the levels of insulin in the body after a meal and decrease the amount of sugar in the body. 
Zdravilo Vipidia deluje tako, da po obroku v telesu zviša koncentracijo insulina in zmanjša količino sladkorja.
The safety and efficacy of Vipidia in children and adolescents < 18 years old have not been established. 
Varnost in učinkovitost zdravila Vipidia pri otrocih in mladostnikih, mlajših od 18 let, nista bili dokazani.
Vipidia is taken when your blood sugar cannot be adequately controlled by diet, exercise and one or more of these other oral anti-diabetic medicines. 
Zdravilo Vipidia uporabljamo, če krvnega sladkorja ni mogoče dovolj dobro nadzorovati z dieto, s telesno vadbo in z enim ali več drugimi peroralnimi zdravili za zdravljenje sladkorne bolezni.
Vipidia should not be used during pregnancy or breast-feeding. 
Zdravila Vipidia med nosečnostjo ali dojenjem ne smete uporabljati.
However, as the distribution of AUC values for alogliptin in these patients was within the same range as control subjects, no dose adjustment for patients with mild renal impairment is necessary (see section 4.2). 
Ker pa je bila porazdelitev vrednosti AUC alogliptina pri teh bolnikih v enakem razponu kot pri kontrolnih osebah, pri bolnikih z blago okvaro ledvic odmerka ni treba prilagajati (glejte poglavje 4.2).
Polychlorotrifluoroethylene (PCTFE)/polyvinyl chloride (PVC) blisters with push through aluminium lidding foil. 
Pretisni omoti iz poliklorotrifluoroetilena (PCTFE)/polivinil klorida (PVC), prekriti s pretisno aluminijasto folijo.
Animal studies have shown excretion of alogliptin in milk (see section 5.3). 
Študije na živalih kažejo na izločanje alogliptina v mleko (glejte poglavje 5.3).
Alogliptin may be administered without regard to the timing of dialysis. 
Alogliptin se lahko uporablja ne glede na čas dialize.
Results from studies with metformin, pioglitazone (thiazolidinedione), voglibose (alpha-glucosidase inhibitor) and glyburide (sulphonylurea) have shown no clinically relevant pharmacokinetic interactions. 
Rezultati študij z metforminom, s pioglitazonom (tiazolidindion), z voglibozo (zaviralec glukozidaze alfa) in gliburidom (sulfonilsečnina) ne kažejo klinično pomembnih farmakokinetičnih interakcij.
- Severe and persistent pain in the abdomen (stomach area) which might reach through to your back, as well as nausea and vomiting, as it could be a sign of an inflamed pancreas (pancreatitis). 
- Huda in trdovratna bolečina v trebuhu (v predelu želodca), ki lahko izžareva v hrbet, pa tudi siljenje na bruhanje in bruhanje, so lahko znak vnetja trebušne slinavke (pankreatitisa).
In addition, a prospective randomised cardiovascular outcomes safety study was conducted with 5,380 patients with high underlying cardiovascular risk to examine the effect of alogliptin compared with placebo (when added to standard of care) on major adverse cardiovascular events (MACE) including time to the first occurrence of any event in the composite of cardiovascular death, nonfatal myocardial infarction and nonfatal stroke in patients with a recent (15 to 90 days) acute coronary event. 
Poleg tega pa je bila izvedena tudi prospektivna randomizirana študija izidov kardiovaskularne varnosti, v katero je bilo vključenih 5.380 bolnikov z velikim osnovnim kardiovaskularnim tveganjem, za ovrednotenje učinka alogliptina v primerjavi s placebom (kot dodatek k standardnemu zdravljenju) na pomembne neželene kardiovaskularne dogodke (MACE, “major adverse cardiovascular events”), vključno s časom do prvega pojava katerega koli dogodka, sestavljenega iz kardiovaskularne smrti, neusodnega miokardnega infarkta in neusodne možganske kapi pri bolnikih z nedavnim (15 do 90 dni) akutnim koronarnim dogodkom.
Nonfatal Stroke *Overall there were 153 subjects (5.7%) in the alogliptin group and 173 subjects (6.5%) in the placebo group who died (all-cause mortality). 
Neusodna možganska kap * V skupini, ki je prejemala alogliptin, je vsega skupaj umrlo 153 oseb (5,7 %), v skupini, ki je prejemala placebo, pa 173 oseb (6,5 %) (umrljivost zaradi vseh vzrokov).
In healthy subjects, alogliptin had no effect on prothrombin time or International Normalised Ratio (INR) when administered concomitantly with warfarin. 
Pri zdravih osebah alogliptin pri sočasni uporabi z varfarinom ni vplival na protrombinski čas ali internacionalno normalizirano razmerje (INR - International Normalised Ratio).
Swallow your tablet(s) whole with water. 
Tableto (tablete) pogoltnite celo (cele) skupaj z vodo.
As a precautionary measure, it is preferable to avoid the use of alogliptin during pregnancy. 
Iz previdnostnih razlogov se je med nosečnostjo uporabi alogliptina bolje izogibati.
Additional symptoms may include general itching and feeling of heat especially affecting the scalp, mouth, throat, palms of hands and soles of feet (Stevens-Johnson syndrome). 
Dodatni simptomi lahko vključujejo splošno srbenje in občutek vročine, še posebej v predelu lasišča, ust, žrela, dlani in podplatov (StevensJohnsonov sindrom).
10 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 60 film-coated tablets 84 film-coated tablets 90 film-coated tablets 98 film-coated tablets 100 film-coated tablets 
10 filmsko obloženih tablet 14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 56 filmsko obloženih tablet 60 filmsko obloženih tablet 84 filmsko obloženih tablet 90 filmsko obloženih tablet 98 filmsko obloženih tablet 100 filmsko obloženih tablet
A single-dose of 50 mg alogliptin was administered to 4 groups of patients with varying degrees of renal impairment (CrCl using the Cockcroft-Gault formula): mild (CrCl = > 50 to ≤ 80 mL/min), moderate (CrCl = ≥ 30 to ≤ 50 mL/min), severe (CrCl = < 30 mL/min) and end-stage renal disease on haemodialysis. 
Enkratni odmerek 50 mg alogliptina so prejele 4 skupine bolnikov z različno stopnjo okvare ledvic ((CrCl po enačbi Cockcroft-Gault): blaga (CrCl = > 50 do ≤ 80 ml/min), zmerna (CrCl = ≥ 30 do ≤ 50 ml/min), huda (CrCl = <30 ml/min) in končna ledvična odpoved na hemodializi.